Bio-engineered Stent Market, by Application Type (Coronary Artery Disease, Peripheral Arterial Disease, Carotid Artery Disease, Renal Artery Stenosis, Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Others), by Product Type (Drug-eluting Stents, Bioabsorbable Stents, and Drug-eluting Balloons), by Mode of Delivery (Balloon-expandable Stents and Self-expanding Stents), by Material Type (Metal-based and Polymer-based), by End User (Hospitals & Cardiac Centers and Ambulatory Surgical Centers, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Industry Insights and Forecast to 2026

  • Published On : Feb 2019 |
  • Pages : 176 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Global Bio-engineered Stent Market – Life Saving Treatment for Cardiovascular Diseases

Bio-engineered stent plays a major role in modern healthcare as it expands the blood vessel to prevent a blockage of arteries in cardiovascular diseases such as coronary heart disease and ischemic heart disease.

The global bio-engineered stent market size was valued at US$ 2,764.2 million in 2017, and is projected to exhibit a CAGR of 8.7% over the forecast period (2018 – 2026).

Figure 1. Global Bio-engineered Stent Market Value (US$ Mn), by Region, 2017

bio-engineered stent market fig-1

Source: Coherent Market Insights Analysis (2019)

Increasing prevalence of cardiovascular diseases such as coronary heart disease and ischemic heart disease is expected to propel growth of the bio-engineered stent market

Bio-engineered stent is used in treating blockage of coronary and peripheral artery, which is related to coronary heart disease, ischemic heart disease, and other cardiovascular diseases. High prevalence of coronary heart disease, ischemic heart disease, and other cardiovascular diseases is expected to propel demand for bio-engineered stent, which in turn is expected to drive the market growth. According to American Heart Association, in 2018, around 92.1 million people in the U.S. were suffering with some form of cardiovascular diseases or the after-effects of stroke. Moreover, around 836,546 deaths in the U.S. were due to cardiovascular diseases, which accounted for 1 in every 3 deaths in the country. Direct and indirect costs in the treatment of cardiovascular diseases and stroke in the country were estimated to be around US$ 329.7 billion in 2018, which includes both health expenditures and lost productivity.

Similarly, according to World Health Organization (WHO), 2015, cardiovascular diseases are the highest cause of morbidity and mortality worldwide, with around 17.7 million cases representing 31% of all worldwide deaths in 2015, of which around 6.7 million were due to stroke and 7.4 million were due to coronary heart disease.

However, availability of alternatives for the treatment of cardiac diseases, product recalls and failure, and stringent regulations for product approvals are expected to hinder the market growth. For instance in November 2017, Abbott recall Class 1 Device Recall Absorb Bioresorbable Vascular Scaffold (BVS) System, a absorbable coronary drug-eluting stent due to elevated rates of major adverse events, specifically, myocardial infraction and scaffold thrombosis when compared to patients treated with the Xience metallic drug eluting stent.

Figure 2. Global Bio-engineered Stent Market Share (%), by Material, 2018 and 2026

bio-engineered stent market fig-2

Source: Coherent Market Insights Analysis (2019)

Increasing adoption of bio-engineered stents in North America is expected to bolster the market growth

North America holds a dominant position in the global bio-engineered stent market, owing to rapid growth in geriatric population, increasing incidences of cardiac ailments, coronary and peripheral artery diseases, and high prevalence of obesity in the region. According to World Population Prospects, the number of people aged 80 or over is projected to triple by 2050, from 137 million in 2017 to 425 million in 2050 in the U.S. This age bracket is expected to more than double worldwide, increasing from 962 million in 2017 to 2.1 billion in 2050.

Moreover, key players in the market are focused on receiving regulatory approvals for novel products to reduce the burden of blood stream infections associated with bio-engineered stents. For instance, in September 2018, Biotronik SE & Co. KG received the U.S. Food and Drug Administration (FDA) approval for PK Papyrus covered coronary stent system for the treatment of acute coronary artery.

Key Players

Major players operating in the global bio-engineered stent market include, Medtronic, plc., Boston Scientific Corporation, Abbott Laboratories, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, MicroPort Scientific Corporation, Stentys Sao, Meril Life Sciences Pvt. Ltd, Vascular Concepts, W. L. Gore and Associates, C. R. Bard, Endologix, Inc., Lombard Medical Technologies, Translumina GmbH, and JOTEC GmbH.

Bio-engineered stents consist of short narrow metal or plastic tube, which is used to treat blocked arteries. It is used by patients who are suffering from different types of cardiovascular diseases such as coronary heart disease and ischemic heart disease. Different types of bio-engineered stent are available in market for various diseases such as coronary artery disease, peripheral arterial disease, carotid artery disease, renal artery stenosis, abdominal aortic aneurysm, thoracic aortic aneurysm among others.

Market Dynamics

Increasing prevalence of renal diseases is a major factor driving bio-engineered stents market growth. According to American Heart Association Council, in 2015, cardiovascular disease was the leading cause of death worldwide, accounting for over 17.9 million deaths annually and this number is expected to increase to over 23.6 million by 2030. According to the same source, cardiovascular diseases accounted for around 836,546 deaths in the U.S. in 2015, which accounted for around 1 in every 3 deaths.

Moreover, key players in the market are focused on adopting various strategies such as new Product Type launch and approvals and partnerships and collaborations to increase their foothold in the market. For instance, in May 2017, Medtronic plc., received the U.S. Food and Drug Administration (FDA) approval and Resolute Onyx, 4.5 MM and 5 mm sizes Drug-Eluting Stent. This device has proven clinical performance and superior deliverability of the Resolute Integrity. This device is intended to treat people with coronary artery disease in the U.S.

However, availability of alternatives for the treatment of cardiac diseases, Product Type recalls and failure, and stringent regulations for Product Type approvals are expected to hinder the market growth. For instance in November 2017, Abbott recall Class 1 Device Recall Absorb Bioresorbable Vascular Scaffold (BVS) System, an absorbable coronary drug-eluting stent due to elevated rates of major adverse events, specifically, myocardial infraction and scaffold thrombosis when compared to patients treated with the Xience metallic drug eluting stent.

Key features of the study:

  • This report provides in-depth analysis of the bio-engineered stents market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global bio-engineered stents market based on the following parameters – company overview, financial performance, Product Type portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Medtronic, plc., Boston Scientific Corporation, Abbott Laboratories, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, MicroPort Scientific Corporation, Stentys Sao, Meril Life Sciences Pvt. Ltd, Vascular Concepts, W. L. Gore and Associates, C. R. Bard, Endologix, Inc., Lombard Medical Technologies, Translumina GmbH, and Jotec GmbH
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Bio-engineered stents market report caters to various stakeholders in this industry including investors, suppliers, Product Type manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the bio-engineered stents market

Detailed Segmentation:

  • Global Bio-engineered Stents Market, By Application Type:
    • Coronary artery disease
    • Peripheral arterial disease
    • Carotid Artery Disease
    • Renal Artery Stenosis
    • Abdominal Aortic Aneurysm
    • Thoracic Aortic Aneurysm
    • Others
  • Global Bio-engineered Stents Market, By Product Type:
    • Drug-eluting Stents
    • Bioabsorbable Stents
    • Drug-eluting Balloons
  • Global Bio-engineered Stents Market, By Mode of Delivery:
    • Balloon-expandable Stents
    • Self-expanding Stents
  • Global Bio-engineered Stents Market, By Material Type:
    • Metal-based
    • Polymer-based
  • Global Bio-engineered Stents Market, By End User:
    • Hospitals & Cardiac Centers
    • Ambulatory Surgical Centers
    • Others
  • Global Bio-engineered Stents Market, By Geography:
    • North America
      • By Application Type:
        • Coronary artery disease
        • Peripheral arterial disease
        • Carotid Artery Disease
        • Renal Artery Stenosis
        • Abdominal Aortic Aneurysm
        • Thoracic Aortic Aneurysm
        • Others
      • By Product Type:
        • Drug-eluting Stents
        • Bioabsorbable Stents
        • Drug-eluting balloons
      • By Mode of Delivery:
        • Balloon-expandable Stents
        • Self-expanding Stents
      • By Material Type:
        • Metal-based
        • Polymer-based
      • By End User:
        • Hospitals & Cardiac Centers
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Application Type:
        • Coronary artery disease
        • Peripheral arterial disease
        • Carotid Artery Disease
        • Renal Artery Stenosis
        • Abdominal Aortic Aneurysm
        • Thoracic Aortic Aneurysm
        • Others
      • By Product Type:
        • Drug-eluting Stents
        • Bioabsorbable Stents
        • Drug-eluting balloons
      • By Mode of Delivery:
        • Balloon-expandable Stents
        • Self-expanding Stents
      • By Material Type:
        • Metal-based
        • Polymer-based
      • By End User:
        • Hospitals & Cardiac Centers
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Application Type:
        • Coronary artery disease
        • Peripheral arterial disease
        • Carotid Artery Disease
        • Renal Artery Stenosis
        • Abdominal Aortic Aneurysm
        • Thoracic Aortic Aneurysm
        • Others
      • By Product Type:
        • Drug-eluting Stents
        • Bioabsorbable Stents
        • Drug-eluting balloons
      • By Mode of Delivery:
        • Balloon-expandable Stents
        • Self-expanding Stents
      • By Material Type:
        • Metal-based
        • Polymer-based
      • By End User:
        • Hospitals & Cardiac Centers
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Application Type:
        • Coronary artery disease
        • Peripheral arterial disease
        • Carotid Artery Disease
        • Renal Artery Stenosis
        • Abdominal Aortic Aneurysm
        • Thoracic Aortic Aneurysm
        • Others
      • By Product Type:
        • Drug-eluting Stents
        • Bioabsorbable Stents
        • Drug-eluting balloons
      • By Mode of Delivery:
        • Balloon-expandable Stents
        • Self-expanding Stents
      • By Material Type:
        • Metal-based
        • Polymer-based
      • By End User:
        • Hospitals & Cardiac Centers
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Application Type:
        • Coronary artery disease
        • Peripheral arterial disease
        • Carotid Artery Disease
        • Renal Artery Stenosis
        • Abdominal Aortic Aneurysm
        • Thoracic Aortic Aneurysm
        • Others
      • By Product Type:
        • Drug-eluting Stents
        • Bioabsorbable Stents
        • Drug-eluting balloons
      • By Mode of Delivery:
        • Balloon-expandable Stents
        • Self-expanding Stents
      • By Material Type:
        • Metal-based
        • Polymer-based
      • By End User:
        • Hospitals & Cardiac Centers
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Application Type:
        • Coronary artery disease
        • Peripheral arterial disease
        • Carotid Artery Disease
        • Renal Artery Stenosis
        • Abdominal Aortic Aneurysm
        • Thoracic Aortic Aneurysm
        • Others
      • By Product Type:
        • Drug-eluting Stents
        • Bioabsorbable Stents
        • Drug-eluting balloons
      • By Mode of Delivery:
        • Balloon-expandable Stents
        • Self-expanding Stents
      • By Material Type:
        • Metal-based
        • Polymer-based
      • By End User:
        • Hospitals & Cardiac Centers
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Medtronic, plc. *
      • Company Overview
      • Product Type Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Boston Scientific Corporation
    • Abbott Laboratories
    • Biotronik SE & Co. KG
    • Braun Melsungen AG
    • Terumo Corporation
    • MicroPort Scientific Corporation
    • Stentys SA
    • Meril Life Sciences Pvt. Ltd
    • Vascular Concepts
    • L. Gore and Associates
    • R. Bard
    • Endologix, Inc.
    • Lombard Medical Technologies
    • Translumina GmbH
    • Jotec GmbH                                       

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Application Type
      • Market Snippet, By Product Type
      • Market Snippet, By Material Type
      • Market Snippet, By Mode of Delivery
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Market Trends
    • Impact Analysis
    • Key Highlights
    • PEST Analysis
    • PORTER’s Analysis
    • Mergers and Acquisitions
    • Epidemiology
  4. Global Bio-engineered Stent Market, By Application Type, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2019– 2026
      • Segment Trends
    • Coronary artery disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
    • peripheral arterial disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
    • Carotid Artery Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
    • Renal Artery Stenosis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
    • Abdominal Aortic Aneurysm
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
    • Thoracic Aortic Aneurysm
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
  5. Global Bio-engineered Stent Market, By Product Type, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2019– 2026
      • Segment Trends
    • Drug-eluting Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
    • Bioabsorbable Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
    • Drug-eluting balloons
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
  6. Global Bio-engineered Stent Market, By Mode of Delivery, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2019– 2026
      • Segment Trends
    • Balloon-expandable Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
    • Self-expanding Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
  7. Global Bio-engineered Stent Market, By Material Type, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2019– 2026
      • Segment Trends
    • Metal-based
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
    • Polymer-based
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
  8. Global Bio-engineered Stent Market, By End User, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2019– 2026
      • Segment Trends
    • Hospitals & Cardiac Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
  9. Global Bio-engineered Stent Market, By Region, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Application Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Mode of Delivery, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Material Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Application Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Mode of Delivery, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Material Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Application Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Mode of Delivery, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Material Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Application Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Mode of Delivery, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Material Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Application Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Mode of Delivery, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Material Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Application Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Mode of Delivery, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Material Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  10. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
    • Company Profiles
      • Medtronic, plc.*
        • Company Overview
        • Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Boston Scientific Corporation
        • Company Overview
        • Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Abbott Laboratories
        • Company Overview
        • Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • BIOTRONIK SE & Co. KG
        • Company Overview
        • Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • B. Braun Melsungen AG
        •  Company Overview
        • Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Terumo Corporation
        • Company Overview
        • Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • MicroPort Scientific Corporation
        • Company Overview
        • Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • STENTYS SA
        • Company Overview
        • Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Meril Life Sciences Pvt. Ltd.
        • Company Overview
        • Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Vascular Concepts
        • Company Overview
        • Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • W. L. Gore and Associates
        • Company Overview
        • Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • C. R. Bard
        • Company Overview
        • Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Endologix, Inc.
        • Company Overview
        • Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Lombard Medical Technologies
        • Company Overview
        • Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Translumina GmbH
        • Company Overview
        • Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • JOTEC GmbH
        • Company Overview
        • Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  11. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 25 market data tables and 29 figures on "Bio-engineered Stent Market - Global forecast to 2026".

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.